Nashville, TN 的 間皮瘤 臨床試驗
8 項針對 間皮瘤 的研究正在 Nashville（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
招募中1 期
- Sarah Cannon Research Institute, Nashville
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
招募中觀察性研究
- Vanderbilt University Medical Center, Nashville
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
招募中1/2 期
- SCRI Oncology Partners, Nashville
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
招募中1/2 期
- Sarah Cannon Tennessee Oncology, Nashville
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
招募中1 期
- Vanderbilt - Ingram Cancer Center, Nashville
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- Sarah Cannon Research Institute at Tennessee Oncology, Nashville
- Tennessee Oncology, Nashville
CT-95 in Advanced Cancers Associated With Mesothelin Expression
招募中1 期
- Context Investigational Site, Nashville
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
招募中1/2 期
- Vanderbilt University Medical Center, Nashville
其他城市的 間皮瘤 試驗
- Houston, TX15 項研究
- New York City, NY10 項研究
- Washington, DC9 項研究
- Chicago, IL9 項研究
- Boston, MA8 項研究
- Los Angeles, CA6 項研究
- Arlington, VA6 項研究
- Pittsburgh, PA6 項研究
- Philadelphia, PA6 項研究
- Seattle, WA6 項研究
- Edison, NJ5 項研究
- Columbus, OH5 項研究
Nashville 的其他研究
- 非小細胞肺癌97 項研究
- 乳癌81 項研究
- 轉移性癌症70 項研究
- 大腸直腸癌69 項研究
- 癌症（所有類型）65 項研究
- 卵巢癌49 項研究
- 前列腺癌43 項研究
- 肺癌40 項研究
- 頭頸部鱗狀細胞癌39 項研究
- 胰臟癌39 項研究
- 子宮內膜癌38 項研究
- 黑色素瘤33 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。